Clinical Trials Directory

Trials / Terminated

TerminatedNCT03717532

Blood Flow Restriction Therapy in Patellofemoral Pain Syndrome

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
1 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the efficacy of blood restriction therapy by comparing increase in muscle mass and strength in patients that receive blood restriction therapy to patients who receive a placebo.

Conditions

Interventions

TypeNameDescription
PROCEDUREPlaceboPatients will be receiving blood flow restriction therapy with a pressure cuff set to a placebo pressure setting.
PROCEDUREPersonalized Tourniquet System for Blood Flow RestrictionPatients will be receiving blood flow restriction therapy with a pressure cuff

Timeline

Start date
2019-02-01
Primary completion
2019-11-01
Completion
2019-11-01
First posted
2018-10-24
Last updated
2020-05-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03717532. Inclusion in this directory is not an endorsement.